Klisyri (250 Mg)
My Prescription
Payment
Select pharmacy
$300.69
Print or send this coupon to your phone
WalmartPowered byAbout Klisyri (250 Mg)
Drug Details
This medication is prescribed for the treatment of actinic keratosis, a specific skin condition that affects the face or scalp.
Price history for Klisyri (250 Mg)
5 Ointments, 1%
Average retail price for Klisyri (250 Mg)
Average SaveHealth price for Klisyri (250 Mg)
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Klisyri (250 Mg) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1% | 5 Ointments | $1,217.98 | $243.60 |
| 1% | 1 Ointment | $250.78 | $250.78 |
Klisyri (250 Mg) FAQs
Klisyri is used for the topical treatment of actinic keratosis on the face or scalp. Actinic keratosis is a rough, scaly patch on the skin caused by years of sun exposure.
Klisyri is not a chemotherapy drug. It is a topical medication used to treat actinic keratosis on the face or scalp.
Yes, Klisyri (tirbanibulin) is FDA approved. It was approved in December 2020 for the topical treatment of actinic keratosis on the face or scalp.
Klisyri is not classified as a chemotherapy cream. It is a topical medication used for the treatment of actinic keratosis on the face or scalp. It contains the active ingredient tirbanibulin, which works by inhibiting cell proliferation.
The cost of Klisyri can be attributed to several factors. These include the research and development expenses involved in bringing a new medication to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, the pricing may reflect the drug's effectiveness, the cost of manufacturing, and the investment in ongoing research. Market exclusivity and the lack of generic alternatives can also contribute to its high price.